SEC Form 4 · accession 0001179110-15-010129
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Wheeler
Officer — President · Director
Period of report
Jun 18, 2015
Accepted (ET)
Jun 22, 2015 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 18, 2015 | M | 125,000 | $16.18 | A | 343,312 | D | |
| Common StockF2 | Jun 18, 2015 | S | 125,000 | $24.22 | D | 218,312 | D | |
| Common StockF4 | Jun 18, 2015 | S | 30,000 | $24.11 | D | 181,032 | I | Craig Wheeler Revocable Trust |
| Common Stock | holding | — | — | — | 150,000 | I | Craig A. Wheeler 2014 Irrevocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $16.18 | Jun 18, 2015 | M | 125,000 | D | Aug 22, 2010 | Aug 22, 2016 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on June 14, 2013.
- F2This transaction was executed in multiple trades at prices ranging from $24.00 to $24.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This sale was effected pursuant to a Rule 10b5-1 Craig Wheeler Revocable Trust trading plan adopted by the reporting person on June 14, 2013.
- F4This transaction was executed in multiple trades at prices ranging from $24.00 to $24.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.